Channel Avatar

VHL Alliance @UCDfXD4DxhuP51VBkSXAp-wA@youtube.com

491 subscribers - no pronouns :c

We are dedicated to improving diagnosis, treatment, and qual


04:12
VHL Awareness Walk Kick Off | May 18th, 2024
05:02
VHL Overview | What Is VHL?
59:41
PRMRP Funding Details Webinar 2024 | VHL Alliance
01:28:25
VHL Veterans Panel | November 2023
01:24:44
VHL 101 | Dr. Othon Iliopoulos, MD, PhD
04:38
Hemangioblastoma and Mosaic Von Hippel Lindau Disease | Elizabeth Sangiorgi
02:36
Meet Amit Tirosh, MD | VHL Researcher | Sheba Medical Center
03:13
Meet John C. Chappell, PhD | VHL Researcher | Virginia Tech Carilion
06:44
Meet Anna Matynia, PhD | VHL Researcher | UCLA
03:20
What Is The VHLA Tumor Board? | Tobias Else, MD, University Of Michigan
01:00:22
Navigating Tough Conversations with Leona de Vinne
30:28
Oncogenic Drivers for VHL Related Pancreatic Neuroendocrine Tumors | Amit Tirosh, MD
28:30
Investigating PIkfyve and Lysosomes as Target in VHL Diseases | Sandra Turcotte, PhD
31:09
Nontraditional Tumor Associated Antigens in ccRCC | William Y. Kim, MD
01:09:17
Keynote: VHL: Gene to Pathway to Precision Management to Therapy | W. Marston Linehan, MD
29:52
VHL and Other Emergent Pseudohypoxic Diseases | Fraser Ferens, PhD
11:58
Tumor Heterogeneity Analysis Using Single Cell Transcriptomics in VHL | Isaline Rowe, PhD
27:17
Natural History and Treatment of Hemangioblastomas in VHL | Othon Iliopoulos, MD, PhD
31:33
Psychosocial Impact of VHL | Rachel van Leeuwaarde, MD, PhD
14:54
Applying a Disease Specific Annotation Protocol for VHL Gene Curation | Sarah Ridd
29:08
FDA Approval of Belzutifan | Eric Jonasch, MD
29:12
Testing Treatments of Ocular Hemangioblastomas Associated with VHL | Emily Chew, MD
29:37
Management of CNS Manifestations of VHL | Prashant Chittiboina, MD
28:38
Hypoxia Inducible Factors Mediate Immune Evasion of Cancer Cells| Gregg L. Semenza, MD, PhD
32:40
Long Term Outcomes in Survivors of Hereditary Childhood Cancer | Paul Nathan, MD, MSc
14:07
Unique Characteristics of VHL Pancreatic Tumors by Diagnostic Criteria | Reut Halperin, MD, PhD
32:51
Management of VHL Associated Pheochromocytoma/Pancreatic Lesions | Electron Kebebew, MD, FACS
01:01:01
Update on Hereditary Pheochromocytoma | Karel Pacak, MD, PhD, DSc, FACE
26:39
Translational Trials for the Early Detection of Kidney Cancer | Christian Hoerner, PhD
13:18
VHL Drug Therapy | Sandy Srinivas, MD
19:28
New Perspectives in the Treatment of CNS VHL | Lawrence Recht, MD
41:39
Systemic Therapy for Von Hippel-Lindau Associated Tumors | Ramaprasad Srinivasan, MD, PhD
30:25
Role Of Renal Ablative Therapy and Minimally Invasive Surgery in VHL Treatment | Benjamin Chung, MD
33:53
Diagnosis & Management of Ocular Manifestations of VHL Disease | Darius Moshfeghi, MD
24:28
5 Life Lessons Gained From Overcoming VHL Adversities | Chris Jankulovski
30:09
Von Hippel-Lindau In Pediatric Patients | Laura Prolo, MD
14:31
Treatment of VHL | Neurological Manifestations In Adults | Steven D. Chang, MD
01:27:23
Genetic Overview & Subtyping of VHL | Nicki Chun, MS, CGC
30:46
Dating, Disclosure and VHL
03:46
Practice Update: Updated Results of Belzutifan for Advanced RCC
59:03
VHLA Town Hall on Welireg
01:39:01
Warrior Call 2022 honoring Dr. Othon Iliopoulos
09:34
Genetic Counseling for VHL
01:22:57
2022 MyVHL Day Celebration Event
06:27
Practice Update: Healthcare Resource Utilization and Costs Among Patients with VHL-Associated RCC
07:45
Practice Update: Belzutifan FDA Approval for VHL-Associated Cancers
01:12:11
Belzutifan: Tratamiento para EVHL
33:29
Welireg (Belzutifan) Q&A Session with Dr. Othon Iliopoulos
01:10
Curing Cancer Through VHL
01:05:17
VHLA Town Hall on Belzutifan (Welireg)
01:00:32
2021 MyVHL Day Celebration Event
05:32
Diversity, Equity, Inclusion, and VHL
03:43
Management of VHL Patients in the Era of COVID-19
14:49
Elysa Bond MS, CGC: Disclosure of Genetic Risk to Dating Partners Among Young Adults with VHL
30:28
CCC Spotlight: Kim Nichols, MD (Oncology, St Jude)
32:19
CCC Spotlight: Gina Nuccio, MS, CGC (Genetic Counseling, St Jude)
27:15
2020 International VHL Medical/Research Symposium: Koen van Overdam, MD
01:10:02
2020 International VHL Medical/Research Symposium Keynote Address: William G. Kaelin Jr., MD
17:17
2020 International VHL Medical/Research Symposium: Axel Bex, MD, PhD
25:16
2020 International VHL Medical/Research Symposium: Betty Gardie, PhD